Patrick Sun Xiong
Dr. Patrick Sun Xiong is an American physician and researcher known for his groundbreaking work in oncology, particularly in the development of innovative treatments for various types of cancer, including lung cancer and glioblastoma. Recently, he gained attention for his advocacy of the cancer drug Anktiva, which has received conditional approval from the Saudi Food and Drug Authority for treating metastatic non-small cell lung cancer (NSCLC). Dr. Xiong has emphasized the importance of this treatment in improving patient survival rates and has highlighted the need for similar approvals from regulatory bodies in the United States.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| North Macedonia | 1 | 9.00 | 0.12% | +0% | 2,083,374 | 2,541 | $12,800 | 16$ |
| Totals | 1 | 2,083,374 | 2,541 | $12,800 | 16$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
North Macedonia:
Dr. Patrick Sun Xiong stated that more than ten years of testing have shown that this drug prolongs the survival of patients with various types of cancer.
9